Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis
Advanced Science · 2023-12 · 10 (35)
DOI: 10.1002/advs.202206932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.11.2023. Verfasst von Xiaoqin Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, P. R. China. Hauptthemen laut MEDLINE: Photochemotherapy, Nanoparticles. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Project of Hunan Health Committee, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Photodynamic therapy (PDT) has been widely employed in tumor treatment due to its effectiveness. However, the tumor hypoxic microenvironment which is caused by abnormal vasculature severely limits the efficacy of PDT. Furthermore, the abnormal vasculature has been implicated in the failure of immunotherapy. In this study, a novel nanoparticle denoted as Combo‐NP is introduced, composed of a biodegradable NIR II fluorescent pseudo‐conjugate polymer featuring disulfide bonds within its main chain, designated as TPA‐BD, and the vascular inhibitor Lenvatinib. Combo‐NP exhibits dual functionality by not only inducing cytotoxic reactive oxygen species (ROS) to directly eliminate tumor cells but also eliciting immunogenic cell death (ICD). This ICD response, in turn, initiates a robust cascade of immune reactions, thereby augmenting the generation of cytotoxic T lymphocytes (CTLs). In addition, Combo‐NP addresses the issue of tumor hypoxia by normalizing the tumor vasculature. This normalization process enhances the efficacy of PDT while concurrently fostering increased CTLs infiltration within the tumor microenvironment. These synergistic effects synergize to potentiate the photodynamic‐immunotherapeutic properties of the nanoparticles. Furthermore, when combined with anti‐programmed death‐ligand 1 (PD‐L1), they showcase notable inhibitory effects on tumor metastasis. The findings in this study introduce an innovative nanomedicine strategy aimed at triggering systemic anti‐tumor immune responses for the treatment of Uveal melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, P. R. China.
- Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China.
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- Institute of Medical Technology, Peking University Health Science Center, Beijing, 100190, P. R. China.
- Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P. R. China.
ORCID-Profile: Gang Tan
Förderung
- National Natural Science Foundation of China
- Science and Technology Project of Hunan Health Committee
- Natural Science Foundation of Hunan Province
- China Postdoctoral Science Foundation
- Science and Technology Program of Hunan Province
Zitieren
APA
Zheng, X., Shi, Y., Tang, D., Xiao, H., Shang, K., Zhou, X., & Tan, G. (2023). Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis. Advanced Science, 10(35). https://doi.org/10.1002/advs.202206932
Vancouver
Zheng X, Shi Y, Tang D, Xiao H, Shang K, Zhou X, et al. Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis. Advanced Science. 2023;10(35). doi:10.1002/advs.202206932
BibTeX
@article{Zheng2023,
author = {Zheng, Xiaoqin and Shi, Yunyi and Tang, Dongsheng and Xiao, Haihua and Shang, Kun and Zhou, Xuezhi and Tan, Gang},
title = {Near‐Infrared‐II Nanoparticles for Vascular Normalization Combined with Immune Checkpoint Blockade via Photodynamic Immunotherapy Inhibit Uveal Melanoma Growth and Metastasis},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {35},
doi = {10.1002/advs.202206932}
}
EUVIMED